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Cancer belongs to the leading causes of mortality in developed countries. Colorectal 
carcinoma is the second most common cancer in the Czech Republic. Due to the 
development of resistance to classical chemotherapeutics, a search for new treatment 
strategies is ongoing.  Prenylflavonoids belong to the natural compounds, which 
express anticancer effect, with xanthohumol and prenylated derivatives of naringenin 
belonging to the often-studied compounds. In this diploma thesis, anticancer 
properties of naringenin and its five semisynthetic prenylated derivates were tested in 
the cell line SW480, which is derived from colorectal carcinoma. Cell viability was 
monitored by the neutral red uptake test after 72 h treatment. For compounds with 
marked anticancer activity, the value of IC50 was determined and the effect of those 
compounds on the cell cycle was determined by flow cytometry. Substantial 
antiproliferative effect was found in four compounds (derivatives A, B, C, and E), 
values of IC50 for these compounds were in the range of 40.41 - 83,67 µM. The highest 
antiproliferative effect was found in derivative C, which was a mixture of isomers of 
compounds A and B. The cell cycle was not influenced by studied compounds.  
 
